uPAR and cFn as candidate protein biomarkers for identifying low response to rtPA in acute ischemic stroke
Abstract Background Recombinant tissue plasminogen activator (rtPA) remains the main therapeutic for acute ischemic stroke (AIS). In clinical practice, the patients with AIS presenting low response to rtPA is commonly observed. Cognizant that the endothelial cell function is impaired in AIS, this st...
Saved in:
| Main Authors: | Yilin Wang, Yuyou Huang, Fangfang Li, Ziping Han, Zhenhong Yang, Liyuan Zhong, Lingzhi Li, Haiping Zhao, Junfen Fan, Yangmin Zheng, Cesario Borlongan, Yumin Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | European Journal of Medical Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40001-025-02772-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RtPA for Submacular Hemorrhage
by: Bartosz Zabrzeński, et al.
Published: (2025-07-01) -
Use of alteplase continuous rate infusion, pentoxifylline, and cyproheptadine in association or not, in acute feline aortic thromboembolism: a study of nine cats
by: Christopher C. Ray, et al.
Published: (2025-05-01) -
Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis
by: Abdelmonam M. Hagag, et al.
Published: (2025-08-01) -
Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR
by: Junwei Hou, et al.
Published: (2015-08-01) -
Recanalization and reperfusion in clinically-relevant porcine model of stroke
by: Błażej Nowak, et al.
Published: (2025-06-01)